Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

BJC reports·2026

Same author

Machine Learning-Based Models to Predict Drug-Induced Liver Injury (DILI) to Assist Medicinal Chemistry.

Journal of medicinal chemistry·2026

Same author

Corrigendum to "Synthesis and biological evaluation of mixed aryl-alkyl succinates as modulators of autophagy and apoptosis in gastric carcinoma" [Bioorg. Chem. 179 (2026) 109997].

Bioorganic chemistry·2026

Same author

Machine learning, whole genome sequencing, and Mendelian randomization support a role of CRP on COVID-19 severity.

Molecular medicine (Cambridge, Mass.)·2026

Same author

Where do we go from here? Current state of drug-target binding kinetics and a roadmap to their establishment in drug discovery campaigns.

Drug discovery today·2026

Same author

Combinatorial histone modifications direct ATP-dependent chromatin remodeling by NURF to promoter-proximal nucleosomes.

Nucleic acids research·2026

Same journal

Advances in virtual screening.

Drug discovery today. Technologies·2024

Same journal

Integration of virtual and physical screening.

Drug discovery today. Technologies·2024

Same journal

A technical overview of supercritical fluid chromatography-mass spectrometry (SFC-MS) and its recent applications in pharmaceutical research and development.

Drug discovery today. Technologies·2021

Same journal

Mass spectrometry based approaches and strategies in bioanalysis for qualitative and quantitative analysis of pharmaceutically relevant molecules.

Drug discovery today. Technologies·2021

Same journal

Drug discovery from natural products using affinity selection-mass spectrometry.

Drug discovery today. Technologies·2021

Same journal

Editorial for the role(s) of MS in drug research and development.

Drug discovery today. Technologies·2021

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

In silico antitarget screening.

Maurizio Recanatini¹, Giovanni Bottegoni¹, Andrea Cavalli¹

¹Department of Pharmaceutical Sciences, University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy.

Drug Discovery Today. Technologies

|July 2, 2014

Summary

This summary is machine-generated.

Predicting drug candidate failure early is crucial in drug discovery. Computational methods help avoid interactions with antitargets, improving drug safety and development success rates.

More Related Videos

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells

Published on: May 24, 2014

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Apr 27, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells

Published on: May 24, 2014

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

Drug Discovery and Development
Computational Chemistry
Pharmacology

Background:

Early prediction of drug candidate failure is essential in modern drug discovery.
Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties are critical during lead development.
Interactions with specific macromolecular targets can cause undesirable side effects, necessitating careful compound design.

Purpose of the Study:

To highlight the importance of early prediction of drug candidate failure.
To emphasize the role of ADMET properties in drug development.
To introduce the application of in silico technologies for avoiding antitarget interactions.

Main Methods:

Review of current drug discovery processes.
Focus on ADMET profiling of drug candidates.
Application of classical in silico technologies for antitarget screening.

Main Results:

Early failure prediction significantly reduces R&D costs and timelines.
Thorough ADMET assessment aids in selecting viable drug candidates.
In silico methods effectively identify potential antitarget interactions.

Conclusions:

Integrating early failure prediction strategies is vital for efficient drug discovery.
Understanding and mitigating ADMET properties are key to successful drug development.
Utilizing in silico tools to avoid antitarget interactions enhances drug safety and efficacy.